Free CME Activity: Heart Failure: Optimizing Medical Therapy and Patient Communication

Start Date: April 1, 2019

Expiration Date: March 31, 2020

Target Audience: Primary Care Physicians, Nurse Practitioners, Physician Assistants

Format: Case-based learning

Estimated Time to Complete: 0.5 hours


AMA accreditation statement

The National Association for Continuing Education designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education and Figure 1.


AANP accreditation statement

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 0.5 contact hours of continuing education.

How to Obtain your CME Certificate:

  1. Complete the pre-test

  2. View the CME activity.

  3. Complete the post-test. You must score at least 66% on the post-test to claim credit.

  4. Complete the evaluation.

  5. Receive email with your CME certificate.


Needs Assessment/Summary

Heart failure (HF) is a growing problem in the United States, affecting an estimated 5.1 million Americans ≥20 years of age. With increased life expectancy, the prevalence of HF is expected to increase 25% by the year 2030, leading to an annual healthcare cost of $70 billion. The disease is associated with several cardiovascular and non-cardiovascular risk factors, including hypertension, coronary artery disease, obesity, diabetes mellitus, HIV infection, and depression.


HF is a cause for even greater concern among certain ethnic groups such as African Americans and Hispanics, in whom it occurs at an earlier age, and is associated with a lower left ventricular ejection fraction (LVEF), and a greater prevalence of risk factors such as diabetes mellitus and hypertension.

This activity will review the role of laboratory testing and imaging for the evaluation and management of heart failure, demonstrate how to reliably assess symptom burden, and examine the use of the current guidelines to create strategies for management and reduction of hospitalization.


Learning objectives

On completion of this program, participants should be able to:


  1. Recognize the role of laboratory testing and imaging in the evaluation and management of heart failure (HF)

  2. Reliably assess symptom burden in patients with HF

  3. Implement ACC/AHA/HFSA guideline-directed medical therapy in the management of chronic heart failure


Sponsored and Certified By

National Association for Continuing Education


Accreditation and Designation Statement

The National Association for Continuing Education designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education and Figure 1.

No commercial support was provided for this CME activity.


Faculty Disclosure Statements

It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed.


Faculty disclosures:

  1. Josh Landy, MD, Internal Medicine Physician and Critical Care Specialist, Toronto, ON. No relationships to disclose.

  2. Sharon Vorona, MBBS, Toronto, ON. No relationships to disclose.

  3. Eldrin F. Lewis, MD, MPH is a contracted researcher for Novartis, Sanofi, and Amgen. He also serves as a consultant for Novartis.

  4. Cedric Nazareth, Medical Writer, has no relationships to disclose.

  5. Harvey C. Parker, Ph.D., has no relationships to disclose.

  6. Gregg Sherman, MD, has no relationships to disclose.

  7. Deborah Paschal, CRNP, has no relationships to disclose.

  8. Michelle Frisch, MPH, has no relationships to disclose.

  9. Daniela Hiedra has no relationships to disclose.

  10. Sandy Bihlmeyer, MEd, has no relationships to disclose.

  11. Alan Goodstat, LCSW, has no relationships to disclose.

  12. Cassandra McCullough, has no financial relationships to disclose

ABOUT FIGURE 1
LEGAL
HOW  FIGURE 1 WORKS
PRESS